(CRNC) Cerence - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1567271093
CRNC: AI, Virtual, Assistants, Speech, Recognition, Software, Services
Cerence Inc. (NASDAQ: CRNC) specializes in AI-driven virtual assistant solutions tailored for the automotive and mobility industries, serving markets globally, including the United States, Europe, the Middle East, Africa, and Asia-Pacific. The companys product portfolio includes edge software components, cloud-connected services, virtual assistant coexistence capabilities, and professional services. Its conversational AI solutions encompass speech recognition, natural language understanding, speech signal enhancement, text-to-speech, and acoustic modeling technology. Cerence was spun off from Nuance Communications in 2020 and is headquartered in Burlington, Massachusetts.
From a technical perspective, CRNC is currently trading at $11.61, below its 20-day SMA of $13.25 and 50-day SMA of $12.40, but above its 200-day SMA of $5.77. The stock faces resistance at $14.3 and $20.1, with support levels at $9.1, $7.4, and $3.1. The average 20-day volume is 3,053,750 shares, with an ATR of $1.92, indicating moderate volatility.
Fundamentally, Cerence has a market cap of $542.15 million, with a forward P/E of 243.90 and a P/B ratio of 4.50. The P/S ratio stands at 2.22, reflecting its revenue multiple. The companys RoE is currently not available due to insufficient data.
Additional Sources for CRNC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CRNC Stock Overview
| Market Cap in USD | 328m |
| Sector | Technology |
| Industry | Software - Application |
| GiC Sub-Industry | Systems Software |
| IPO / Inception | 2019-10-02 |
CRNC Stock Ratings
| Growth Rating | -40.9 |
| Fundamental | -11.7 |
| Dividend Rating | 0.0 |
| Rel. Strength | -10.1 |
| Analysts | 3.29/5 |
| Fair Price Momentum | 7.31 USD |
| Fair Price DCF | 7.09 USD |
CRNC Dividends
No Dividends PaidCRNC Growth Ratios
| Growth Correlation 3m | -86.4% |
| Growth Correlation 12m | 62.3% |
| Growth Correlation 5y | -86.6% |
| CAGR 5y | -15.07% |
| CAGR/Max DD 5y | -0.15 |
| Sharpe Ratio 12m | -1.04 |
| Alpha | -19.36 |
| Beta | 1.630 |
| Volatility | 118.16% |
| Current Volume | 713.4k |
| Average Volume 20d | 963.1k |
As of May 02, 2025, the stock is trading at USD 9.22 with a total of 713,351 shares traded.
Over the past week, the price has changed by +3.25%, over one month by +16.86%, over three months by -18.91% and over the past year by -0.75%.
Neither. Based on ValueRay Fundamental Analyses, Cerence is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -11.71 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRNC as of May 2025 is 7.31. This means that CRNC is currently overvalued and has a potential downside of -20.72%.
Cerence has received a consensus analysts rating of 3.29. Therefor, it is recommend to hold CRNC.
- Strong Buy: 1
- Buy: 0
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CRNC Cerence will be worth about 8.3 in May 2026. The stock is currently trading at 9.22. This means that the stock has a potential downside of -10.52%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 11.6 | 25.6% |
| Analysts Target Price | 7.2 | -21.9% |
| ValueRay Target Price | 8.3 | -10.5% |